Oxidative stress and disturbed glutamate transport in hereditary nucleotide repair disorders

Journal of Neuropathology and Experimental Neurology

Volumn 60, Issue 4, 2001, Pages 350-356

  Hayashi, Masaharu ^a   Itoh, Masahiro ^a   Araki, Satoshi ^b   Kumada, Satoko ^a   Shioda, Kei ^c   Tamagawa, Kimiko ^b   Mizutani, Toshio ^b   Morimatsu, Yoshio ^a   Minagawa, Masao ^c   Oda, Masaya ^b  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b TOKYO METROPOLITAN NEUROLOGICAL HOSPITAL   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cockayne syndrome; Glutamate transporter; Nucleotide repair; Oxidative stress; Xeroderma pigmentosum

Indexed keywords

3 NITROTYROSINE; 4 HYDROXYNONENAL; ADVANCED GLYCATION END PRODUCT; EXCITATORY AMINO ACID TRANSPORTER 1; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; PROTEIN; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER 1;

ADULT; ARTICLE; CEREBELLUM DEGENERATION; CLINICAL ARTICLE; COCKAYNE SYNDROME; CONTROLLED STUDY; DENTATE NUCLEUS; DNA REPAIR; FEMALE; GLOBUS PALLIDUS; HEREDITARY NUCLEOTIDE REPAIR DISORDER; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NERVE DEGENERATION; NEUROPIL; NEUROTOXICITY; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPHEROID CELL; TISSUE DISTRIBUTION; XERODERMA PIGMENTOSUM;

EID: 0035057412     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/60.4.350     Document Type: Article

References (29)

1. Neurodegeneration in hereditary nucleotide repair disorders
2. Cerebellar neurodegeneration in human hereditary DNA repair disorders
3. Oxidative stress in neurodegenerative disease
4. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis
5. Immunohistochemical study of advanced glycation end products in aging and Alzheimer's disease brain
6. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease
7. Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression
8. Selective loss of glial glutamate transporter GET-1 in amyotrophic lateral sclerosis
9. Cerebellar degeneration in hereditary dentatorubral-pallidoluysian atrophy and Machado-Joseph disease
10. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts
11. Immunohistochemical approach to characterize advanced glycation end products of the Maillard reaction
12. N-(carboxymethyl) lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction
13. The monoclonal antibody specific for the 4-hydroxy-2-nonenal histidine adduct
14. Functional expression of a GLT-1 type Na+ - Dependent glutamate transporter in rat pinealocytes
15. Grumose or foamy spheroid bodies involving astrocytes in the human brain
16. Widespread peroxynitrite-mediated damage in Alzheimer's disease
17. Hereditary ceruloplasmin deficiency increases advanced glycation end products in the brain
18. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease
19. Immunohistochemical and ultrastructural detection of the advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody
20. Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy
21. Free radical scavengers: Chemical concepts and clinical relevance
22. Defects in antioxidant defense and calcium transport in the epidermis of xeroderma pigmentosum
23. Localization of neural and glial glutamate transporter
24. Distribution of glutamate transporter subtypes during human brain development
25. High incidence of ultraviolet-B- or chemical-carcinogen-induced skin tumors in mice lacking the xeroderma pigmentosum group A gene
26. Defective transcription-coupled repair in Cockayne syndrome B mice is associated with skin cancer predisposition
27. Do dopamine agonists provide neuroprotection?
28. Do the benefits of currently available treatments justify early diagnosis and treatment of amyotrophic lateral sclerosis?